Combining CRP and CA19-9 in a novel prognostic score in pancreatic ductal adenocarcinoma
Abstract Inflammation promotes tumor progression, induces invasion and metastatic spread. This retrospective study explored CRP, CA19-9, and routine laboratory values as preoperative prognostic factors in pancreatic cancer patients. Between 2000 and 2016, there were 212 surgically treated pancreatic...
Main Authors: | Anna M. Nurmi, Harri K. Mustonen, Ulf-Håkan Stenman, Hanna E. Seppänen, Caj H. Haglund |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-01-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-020-80778-0 |
Similar Items
-
Systemic Inflammatory Response and Elevated Tumour Markers Predict Worse Survival in Resectable Pancreatic Ductal Adenocarcinoma.
by: Aino Salmiheimo, et al.
Published: (2016-01-01) -
Prognostic and diagnostic value of REG4 serum and tissue expression in pancreatic ductal adenocarcinoma
by: Kapo Saukkonen, et al.
Published: (2018-03-01) -
Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma.
by: Kapo Saukkonen, et al.
Published: (2015-01-01) -
Nuclear ubiquitin C-terminal hydrolase L5 expression associates with increased patient survival in pancreatic ductal adenocarcinoma
by: Leena Arpalahti, et al.
Published: (2017-06-01) -
Impact of histological response after neoadjuvant therapy on podocalyxin as a prognostic marker in pancreatic cancer
by: Annika Eurola, et al.
Published: (2021-05-01)